ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Bright Minds Biosciences Inc

Bright Minds Biosciences Inc (DRUG)

38.4178
-0.6922
( -1.77% )
Updated: 12:35:33

Bright Minds Biosciences Inc Financial Summary

The current DRUG market cap is 266.95M. The company's latest EPS is CAD -1.0610 and P/E is -36.21.

Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
CAD ($)CAD ($)CAD ($)
Total Revenue 00000
Operating Income -2.23M-2.24M-1.45M-814k228k
Net Income -1.46M-1.53M-1.68M-574k230k
Year End September 29 2023 202120222023
CAD ($)CAD ($)CAD ($)
Total Revenue 000
Operating Income -7.68M-13.31M-6.56M
Net Income -8.65M-14.97M-7.37M
Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
CAD ($)CAD ($)CAD ($)
Total Assets 8.46M6.88M6.89M6.53M6.28M
Total Liabilities 735k281k854k846k178k
Total Equity 7.73M6.6M6.03M5.69M6.1M
Year End September 29 2023 202120222023
CAD ($)CAD ($)CAD ($)
Total Assets 20.04M12.09M6.88M
Total Liabilities 639k1.54M281k
Total Equity 19.4M10.54M6.6M
Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
CAD ($)CAD ($)CAD ($)
Operating -5.83M-7.03M-822k-1.63M-1.39M
Investing N/A N/A N/A N/A N/A
Financing 2.21M2.19M878k856k834k
Year End September 29 2023 202120222023
CAD ($)CAD ($)CAD ($)
Operating -7.32M-13.59M-7.03M
Investing N/A N/A N/A
Financing 26.06M5.2M2.19M
Market Cap 266.95M
Price to Earnings Ratio -36.21
Price to Sales Ratio 0
Price to Cash Ratio 39.56
Price to Book Ratio 40.46
Dividend Yield -

Share Statistics

Shares Outstanding 6.95M
Average Volume (1 week) 96.88k
Average Volume (1 Month) 156.31k
52 Week Change 2,586.56%
52 Week High 79.02
52 Week Low 0.93
Spread (Intraday) 0.58 (1.5%)

Company Info

Company Name Bright Minds Biosciences Inc
Address 1500 - 1055 west georgia street
vancouver, british columbia V6E 4N7
Website https://www.brightmindsbio.com
Industry pharmaceutical preparations (2834)